The owners of a drug wholesaler have been indicted for their alleged role in a conspiracy to distribute misbranded and diverted HIV pills, the latest effort by federal authorities to target a widespread scheme to pump the medicines into the U.S. pharmaceutical supply chain.
Patrick Boyd and Charles Boyd, who own Safe Chain Solutions, along with a broker, Adam Brosius, were indicted for allegedly buying more than $90 million of “heavily discounted” prescription drugs from a handful of black-market suppliers. Prosecutors said these diverted medicines — mostly HIV pills — were often obtained through unlawful buybacks, in which previously dispensed bottles were purchased from patients.
The drugs were then resold to Safe Chain with falsified documentation designed to conceal the true source of the medications, according to the indictment. The indictment further said that, after purchasing HIV medicines from the black-market suppliers, the owners of the wholesaler sold the diverted drugs to pharmacies throughout the U.S. Pharmacies then dispensed the diverted HIV pills to unsuspecting patients.
This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.
Already have an account? Log in
Already have an account? Log in
About the Author Reprints
To submit a correction request, please visit our Contact Us page.
STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect